Table 1 Baseline characteristics.
Feature | Value |
|---|---|
Gender, female | 52 (85.2) |
Age (mean ± SD), y | 36.8 ± 10.2 |
BMI (mean ± SD), kg/m2 | 27.8 ± 4.4 |
Hypertension | 19 (31.1) |
Dyslipidemia | 2 (3.3) |
Clinical duration | |
Onset to EVT, median (IQR), months | 4 (1, 12) |
Aggravation to EVT, median (IQR), days | 30 (30, 60) |
Clinical presentation | |
Headache | 36 (59.0) |
Tinnitus | 12 (19.7) |
Visual dysfunction | 50 (82.0) |
Binoculus | 41 (67.2) |
Ocellus | 9 (14.8) |
Vision acuity decline | 42 (68.9) |
Visual field defect | 5 (8.2) |
Dysmorphopsia | 3 (4.9) |
Amaurosis | 7 (11.5) |
Diplopia | 5 (8.2) |
Ophthalmic examination | |
Papilledema | 52 (85.2) |
Vision acuity (mean ± SD) | |
Left | 0.81 ± 0.35 |
Right | 0.81 ± 0.37 |
Lumbar pressure, (mean ± SD), mm H2O | 300.9 ± 46.1 |
Location of stenosis, No. (%) | |
Ts | 12 (19.7) |
Ts-SigS | 45 (73.8) |
Ts and SigS | 2 (3.3) |
Ts and Ts-SigS | 1 (1.6) |
SSS and Ts | 1 (1.6) |
Laterality of stenosis | |
Lt, Rt nomal | 1 (1.6) |
Rt, Lt nomal | 9 (14.8) |
Bilateral | 14 (23.0) |
Lt, Rt hp or occlusion | 5 (8.2) |
Rt, Lt hp or occlusion | 32 (52.2) |
